Natera News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

22.09.17	Natera Selected for Circulating Tumor DNA Study in Bladder Cancer (PR Newswire)
22.09.17	Natera sélectionnée pour une étude sur l'ADN tumoral circulant dans le cadre du cancer de la vessie (PR Newswire)
22.09.17	Natera für Studie zu Zirkulierender Tumor-DNA bei Blasenkrebs ausgewählt (PR Newswire)
20.09.17	Natera Selected for Circulating Tumor DNA Study in Bladder Cancer (PR Newswire)
11.09.17	Cavium and Enea Deliver Optimized Software and Hardware Platform for uCPE (PR Newswire)
21.08.17	Natera Launches Signatera™ Personalized Circulating Tumor DNA Technology for Cancer Research (PR Newswire)
10.08.17	Gainers & Losers Of Aug.9: NTRA, ACHN, OMER, SGRY, PGNX... (RTTNews)
08.08.17	Natera Reports Second Quarter 2017 Financial Results (PR Newswire)
01.08.17	Natera Inc. Announces Second Quarter 2017 Earnings Conference Call (PR Newswire)
13.06.17	Coalition for Access to Prenatal Screening Announces Clinical Advisory Board (PR Newswire)
08.05.17	Natera, Inc. Announces Launch of Vistara Single-Gene Mutation NIPT (PR Newswire)
04.05.17	Natera Announces the Appointment of Gail Marcus as Member of the Board of Directors (PR Newswire)
02.05.17	Natera Inc. Announces First Quarter 2017 Earnings Conference Call (PR Newswire)
26.04.17	Study in Nature Shows Early Relapse Detection in Lung Cancer Using Natera's Technology for ctDNA Analysis (PR Newswire)
07.03.17	Natera Reports Fourth Quarter and Fiscal Year 2016 Financial Results (PR Newswire)
01.03.17	Natera, Inc. Announces Launch of Evercord™ Cord Blood and Tissue Banking Service (PR Newswire)
17.01.17	Natera Announces Results From DNAFirst Study, Validating Use Of NIPT In Routine Prenatal Care (PR Newswire)
10.01.17	Natera Inc. Terminates NIPT Distribution Agreement with Bioreference Labs (PR Newswire)
04.01.17	Leading Genetic Testing Companies Join Forces to Launch the Coalition for Access to Prenatal Screening (PR Newswire)
14.12.16	Natera Announces Participation In I-SPY 2 TRIAL For Breast Cancer (PR Newswire)
01.12.16	The Centers For Medicare And Medicaid Services Establishes 2017 Pricing For Aneuploidy And Microdeletion Testing (PR Newswire)
22.11.16	Natera to Present at the 28th Annual Piper Jaffray Health Conference (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.14	1.54 %	K V
UBS Group	28.08	1.48 %	K V
Swiss Re	130.05	1.05 %	K V
Part Grp Hldg	1’266.00	0.96 %	K V
ABB	49.48	0.94 %	K V
Geberit	525.20	0.27 %	K V
Alcon	78.04	0.05 %	K V
Givaudan	3’868.00	-0.31 %	K V
CieFinRichemont	121.20	-0.57 %	K V
Sonova Hldg	301.00	-0.99 %	K V